← Open Payments lookup

DALLAS CLARK: Open Payments

NPI 1578234357 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,224 in 106 payments from 33 companies in 2025. Trend: 2023 $3,176 · 2024 $3,414 · 2025 $2,224

Food & beverage: $2,224
CompanyPaymentsAmount
Novo Nordisk Inc13$239
Amgen Inc.10$188
ABBVIE INC.13$175
Xeris Pharmaceuticals, Inc.9$161
Abbott Laboratories3$160
Dexcom, Inc.5$156
BETA BIONICS, INC.6$135
Bayer Healthcare Pharmaceuticals Inc.5$107
Almatica Pharma LLC4$100
Alexion Pharmaceuticals, Inc.3$68

Products named: FREESTYLE LIBRE 3, Dexcom G6 Transmitter, Ozempic, iLet Bionic Pancreas, Kerendia, Wegovy, TERIPARATIDE, RECORLEV.

Industry payments across NV — which companies pay providers there.